PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeiq Regulatory News (HEIQ)

Share Price Information for Heiq (HEIQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.15
Bid: 13.00
Ask: 14.10
Change: 1.075 (8.22%)
Spread: 1.10 (8.462%)
Open: 13.00
High: 14.15
Low: 13.00
Prev. Close: 13.075
HEIQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

HeiQ Viroblock Agreement with ICP

19 Mar 2021 07:00

RNS Number : 7931S
HeiQ PLC
19 March 2021
 

 

This article is not intended to be distributed in the USA.

 

 

19 March 2021

 

HeiQ Plc

("HeiQ" or "the Company")

 

HeiQ Viroblock Agreement with ICP

 

HeiQ (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that it has signed an Exclusive Licence and Chemicals Supply Agreement with ICP Industrial Inc, a division of ICP Group ("ICP"), the global leader in the development, application, and technical support of innovative thin film coatings which are applied to packaging used by the FMCG, pharmaceuticals and medical sectors.

 

The two companies have signed a five year contract (US$8m in the first two years, at which point the contract is subject to renewal) which is expected to deliver US$30m of royalty revenue to the Company ("the Minimum Exclusive Requirement") in exchange for exclusive worldwide rights to apply HeiQ Viroblock to coatings for printing processes such as commercial print, food, beverage and pharma packaging. ICP will market its products with the HeiQ Viroblock technology and trademarks to its downstream customers, which manufacture packaging products for some of the world's largest consumer brands. This will enable brand owners to market products packaged in materials with antimicrobial properties to consumers. The two companies are currently completing the product development, due to be finalized at the latest by 1st August 2021, following which the exclusivity period begins. HeiQ will supply ICP with HeiQ Viroblock, an antimicrobial technology proven to destroy over 99.99% of infectious viruses and bacteria within minutes, and will receive a percentage of ICP's net sales in the form of royalties, in line with its strategy to grow its high margin royalty and licensing business. The partnership enables HeiQ to bring its market leading antimicrobials and other HeiQ technologies into several new industry fields served by ICP.

 

HeiQ co-founder and CEO Carlo Centonze said:

 

"This multi-year agreement with a global print and packaging coating leader builds on our recent contract to apply HeiQ Viroblock to paint, demonstrating that HeiQ Viroblock and antimicrobial technology is becoming mainstream for all materials that we touch in our daily lives. It is with great pleasure that we team up with ICP Industrial Inc, a global leader which provides the print and packaging industry with advanced coating technologies. It is of paramount importance given that the global pandemic has shown that viruses can remain infectious on paper and cardboard for several days. These recent agreements relating to HeiQ Viroblock being adopted by businesses outside of the textile industry also highlight that our award-winning innovation has entered a new phase in its lifecycle and that the brand equity we have built as an innovation leader is delivering meaningful returns. Subject to a successful trial period, we believe that this royalty arrangement has the potential to deliver strong, high margin sales for HeiQ and to strengthen our brand equity significantly, through uptake by ICP's blue chip client base."

 

ICP Industrial's Division President Paul Grzebielucha said:

 

"We are excited to offer this new innovative life-saving technology to the print world. We have global reach under our brands of Nicoat, MinusNine and Hitech Coatings to provide this protection on billions of printed surfaces per year. This HeiQ Viroblock game changing technology for our industry and society has proven to be a superior solution that is currently available in the marketplace. HeiQ products have proven efficacy in terms of destroying infectious viruses in minutes rather than hours with an effective rate of 99.95%. ICP Industrial has always provided innovative solutions to the graphic arts and packaging segments while maintaining the highest level of customer and technical service in the industry. ICP Industrial is very excited about the partnership with HeiQ bringing this technology to market providing a safer touch environment to the world."

 

For further information, please contact:

 

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Arlington Group Asset Management Limited (Financial Advisor and Joint Broker)

Charles Cannon Brookes

+44 (0) 207 389 5017

Cenkos Securities plc (Joint Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Robin Tozer / Megan Kovach

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 

About HeiQ

HeiQ is a pioneer and at the forefront of global technology in the $10 billion antimicrobial fabrics and $24 billion textile chemicals market. With the focus on materials and textile innovation, HeiQ has created some of the most effective, durable and high-performance technologies and textile effects in the market today, which cool, warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has developed over 200 technologies in partnership with 300 major brands.

 

HeiQ is a high intellectual capital company which has successfully built up a reputation in textile technologies, having won multiple awards and innovating with leading eco-conscious brands such as Patagonia.

 

Led by an experienced management team, HeiQ rapidly researches new solutions for partners, quickly delivers scaled up manufacturing from its sites across the world and helps partners market the product to end consumers - aiming for lab to consumer in months.

 

HeiQ aims to deliver growth for its shareholders through a combination of increased sales of its core products and by entering additional lucrative markets through disruptive innovations.

 

 

About ICP

 

ICP Industrial Inc, a division of Innovative Chemical Products ("ICP Group") is a global leader in the development, application & technical support of innovative specialty coatings for the graphic arts industry. ICP Industrial's platform, led by trusted brands Nicoat®, MinusNine and Hitech Coatings, delivers innovative solutions to the packaging, labeling and graphic arts industries. The ICP R&D team, Technical Service and Technical Sales Managers support customers to leverage the high-performance portfolio of aqueous, UV/LED/EB, silicone and specialty coatings and adhesive technologies with operations headquartered in Itasca, Illinois. ICP Industrial manufacture these coatings in multiple facilities around the world.

 

The expanding ICP Group specializes in manufacturing and distributing professional products for building envelopes, flooring, sport surfaces, packaging and specialty print. Founded in 2015 and supported by a lean corporate team, ICP Group has scaled rapidly through organic and acquisition growth into one of the largest coatings, adhesives, and sealants companies in North America. ICP Group is privately held and manufactures products under several recognized specialty groups. For more information, visit www.icpindustrial.com or www.icpgroup.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUWVARAWUOAUR
12
Date   Source Headline
22nd Apr 20247:00 amRNSHeiQ Synbio Secures Ecolab Contract Win
16th Apr 20242:17 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSUnaudited Interim Results
18th Mar 202412:41 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSHolding(s) in Company
14th Mar 20241:23 pmRNSCompletion of Fundraising, PDMR & Audit Update
13th Mar 20242:26 pmRNSResult of General Meeting
12th Mar 20247:00 amRNSBoard Changes
23rd Feb 20247:00 amRNSResult of Retail Offer
16th Feb 20247:00 amRNSResult of Placing
15th Feb 20245:49 pmRNSRetail Offer
15th Feb 20245:46 pmRNSAcquisition, Fundraising, Trading Update & GM
6th Dec 20232:46 pmRNSAgreed Changes to Concert Party
4th Dec 20237:00 amRNSDirector/PDMR Dealing
1st Dec 20233:04 pmRNSResult of General Meeting
30th Nov 20237:06 amRNSStatement Confirming Settlement
27th Nov 20237:00 amRNSBoard Appointment
8th Nov 20237:00 amRNSNotice of General Meeting
3rd Nov 20239:14 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
31st Oct 20237:43 amRNSFiling of Annual Report & Restoration of Trading
31st Oct 20237:30 amRNSRestoration - HEIQ PLC
30th Oct 20237:01 amRNSInterim Results
30th Oct 20237:00 amRNSResults for year ended 31 December 2022
23rd Oct 20237:00 amRNSNotice of Results and Audit Update
29th Sep 20237:00 amRNSAccounts Update
6th Jul 20237:00 amRNSMAS Holdings invests in HeiQ AeoniQ
29th Jun 20232:16 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
6th Jun 20237:00 amRNSNotice of AGM
2nd May 20237:44 amRNSTemporary Suspension of Trading in Ordinary Shares
27th Apr 20233:55 pmRNSTemporary Suspension
13th Jan 20232:09 pmRNSUpdate re. admission of Consideration Shares
12th Jan 20237:00 amRNSCompletion of Acquisition
10th Jan 20237:00 amRNSDirector / PDMR Dealing
6th Jan 20237:00 amRNSDirector / PDMR Dealing
5th Jan 20237:03 amRNSDirector/PDMR Shareholding
4th Jan 20237:00 amRNSTrading Update and Acquisition
14th Dec 20227:00 amRNSIncreased interest in HeiQ Chrisal to 71%
2nd Dec 20227:00 amRNSAcquisition of Chem-Tex Laboratories, Inc
7th Nov 20227:00 amRNSChange of Auditor
10th Oct 20227:00 amRNSFiles Breach of Exclusive Agreement Complaint
13th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSNotice of H1 2022 Results and Presentation
8th Aug 202210:33 amRNSIssue of Equity and Total Voting Rights
29th Jun 202211:06 amRNSResult of AGM
14th Jun 20227:00 amRNSCommercial progress of HeiQ’s Hygiene technologies
18th May 20227:00 amRNSNotice of AGM
12th May 20227:00 amRNSPayment of Earnout Consideration
28th Apr 20227:00 amRNSResults for the year ended 31 December 2021
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.